PD-L1-regulated tumor immune resistance includes innate resistance caused by endogenously constitutive PD-L1 expression and adaptive resistance caused by exogenous stimuli-induced PD-L1 expression [95,98]. The gene discussed is CD274; the disease is neoplasm.